FFM
IMGN

Fairmount Funds Management’s Immunogen Inc IMGN Stock Holding History

Fairmount Funds Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,929,592
Closed -$176M – 18
2023
Q4 		$176M Hold
5,929,592
– – 18.58% 2
2023
Q3 		$94.1M Sell
5,929,592
-100,000
-2% -$1.66M 11.32% 3
2023
Q2 		$114M Buy
+6,029,592
New +$71.2M 16.04% 3

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Fairmount Funds Management's IMGN Position: Q1 2024 in Review

Fairmount Funds Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 5,929,592 shares — an estimated $176M sold.

Fairmount Funds Management first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $176M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Fairmount Funds Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Fairmount Funds Management sold 5,929,592 Immunogen Inc shares in Q1 2024, an estimated $176M.
  • Fairmount Funds Management first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Fairmount Funds Management's Immunogen Inc position peaked at $176M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Fairmount Funds Management's 13F filing for Q1 2024, filed 15 May 2024.